Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

The effect of genetic variability on drug response in conventional breast cancer treatment.

European journal of pharmacology - 25 Dec 2009

Wiechec Emilia, Hansen Lise Lotte

Abstract excerpt

The conventional breast cancer diagnosis based mainly upon histopathology, hormone and HER-2 receptor status, will in the future be combined with information on genomic and epigenetic profiles of the individual patient. This will lead to an optimal personalized therapy, directed towards specific genomic aberrations, avoiding unnecessary toxicity, side effects and chemotherapeutic drugs for which the patient...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Antineoplastic Agents
Share to Breast Neoplasms
Share to Drug Delivery Systems

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Drug Resistance, Neoplasm

Share to Genetic Variation

Share to Genotype

Share to Polymorphism, Single Nucleotide

Source

Identifiers

PMID: 19836373
DOI: 10.1016/j.ejphar.2009.08.045

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

The effect of genetic variability on drug response in conventional breast cancer treatment.PMID 19836373Read ↗

Pharmacogenomics in breast cancer: current trends and future directions.Semantic proximity Read ↗

Pharmacogenomics and breast cancer.Semantic proximity Read ↗

Genomics and pharmacogenomics of breast cancer: current knowledge and trends.Semantic proximity Read ↗

Pharmacogenetics of Chemotherapy Efficacy in Breast CancerSemantic proximity Read ↗

The Role of Pharmacogenetic-Based Pharmacokinetic Analysis in Precise Breast Cancer TreatmentSemantic proximity Read ↗

Single Nucleotide Polymorphisms as the Efficient Prognostic Markers in Breast Cancer.Semantic proximity Read ↗

Genetic Influences in Breast Cancer Drug ResistanceSemantic proximity Read ↗

Toxicity and Pharmacogenomic Biomarkers in Breast Cancer ChemotherapySemantic proximity Read ↗

Investigation of association between natural variants in sub-cellular pathways and breast cancer chemotherapy responseSemantic proximity Read ↗

Genetic heterogeneity in breast cancer: the road to personalized medicine?Semantic proximity Read ↗

The implications of genetic variation for the pharmacokinetics and pharmacodynamics of aromatase inhibitors.Semantic proximity Read ↗

Precision medicine in breast cancer: genes, genomes, and the future of genomically driven treatments.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.